<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA2685AB-275C-4612-8454-D90790672A46"><gtr:id>BA2685AB-275C-4612-8454-D90790672A46</gtr:id><gtr:name>York University Canada</gtr:name><gtr:address><gtr:line1>4700 Keele Street</gtr:line1><gtr:line4>Toronto</gtr:line4><gtr:line5>Ontario M3J 1P3</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AC5C544E-DE82-4B6F-BEA2-0E303B51B736"><gtr:id>AC5C544E-DE82-4B6F-BEA2-0E303B51B736</gtr:id><gtr:name>Beckman Research Institute City of Hope</gtr:name><gtr:address><gtr:line1>Beckman Research Institute City of Hope</gtr:line1><gtr:line2>1500 East Duarte Road</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA2685AB-275C-4612-8454-D90790672A46"><gtr:id>BA2685AB-275C-4612-8454-D90790672A46</gtr:id><gtr:name>York University Canada</gtr:name><gtr:address><gtr:line1>4700 Keele Street</gtr:line1><gtr:line4>Toronto</gtr:line4><gtr:line5>Ontario M3J 1P3</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AC5C544E-DE82-4B6F-BEA2-0E303B51B736"><gtr:id>AC5C544E-DE82-4B6F-BEA2-0E303B51B736</gtr:id><gtr:name>Beckman Research Institute City of Hope</gtr:name><gtr:address><gtr:line1>Beckman Research Institute City of Hope</gtr:line1><gtr:line2>1500 East Duarte Road</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D211DBE-80C6-4047-B5A2-2CDC1CCD0B2E"><gtr:id>9D211DBE-80C6-4047-B5A2-2CDC1CCD0B2E</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Boutell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12014%2F5"><gtr:id>97B20DD9-198D-42E4-B769-0282DD329D90</gtr:id><gtr:title>Analysing the Role of Ubiquitin and Ubiquitin-like Modification During Herpesvirus Infection and Host Immunity</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12014/5</gtr:grantReference><gtr:abstractText>Dr Chris Boutell, Lead Investigator, MRC-University of Glasgow Centre for Virus Research (CVR), University of Glasgow
The modification of proteins regulates many important aspects of cell biology, including host immunity to infection. Viruses have therefore evolved strategies to utilise or suppress pathways that regulate protein modification to overcome host defences to infection, thereby enhancing their replication, spread, and disease burden. However, these key interactions remain largely undefined at a biochemical level. Work within this programme focuses on two pathways, namely ubiquitin and SUMO (Small Ubiquitin-like MOdifier), which we and others have shown to play an important role in the regulation of host immunity. Our aim is to define the activity of core enzymes that influence the outcome of infection, using herpes simplex virus 1 (HSV-1) as a model DNA virus. These studies will reveal unique insight into the mechanisms that regulate host immunity during DNA virus infection, as well as uncovering fundamental principles that regulate other important areas of cell biology relevant to human disease, for example carcinogenesis. By understanding these principles we aim to develop new targeted approaches for future therapeutic intervention to treat viral infections pertinent to public health.</gtr:abstractText><gtr:technicalSummary>The post-translational modification (PTM) of proteins by ubiquitin and ubiquitin-like (UBL) polypeptides regulates many fundamental aspects of cell biology, including multiple facets relating to host immunity. Viruses have therefore evolved mechanisms to utilise or suppress these PTM pathways to overcome host immune defence mechanisms during infection, thereby promoting their replication and spread. Understanding the biochemical interplay between viral and host factors which utilise these pathways will therefore lead to new insights into the regulation of host immunity, processes which restrict the replication of many clinically important viruses. This programme aims to define the biochemistry of key viral host-cell interactions that utilise ubiquitin and SUMO PTM pathways to influence the outcome of host immunity during herpesvirus infection, using HSV-1 as a model system. By defining the biochemistry of these interactions we aim to: significantly advance our understanding of the signalling mechanisms that mediate the cellular restriction of herpesviruses and the establishment of viral latency; uncover fundamental principles relating to the regulation of ubiquitin and SUMO ligases that mediate key aspects of cellular immunity during HSV-1 infection; develop methodologies suitable for the identification of viral ubiquitin ligase inhibitors using ICP0 as a model ligase.
This programme will add significant value to the MRC, CVR, and its associated research partners through the delivery of an interdisciplinary and internationally competitive programme of research. This programme will strengthen the study of ubiquitin and ubiquitin-related pathways within the CVR in other virus systems, including influenza A virus (IAV), Hepatitis C Virus (HCV), and selected arboviruses, through the dissemination of research reagents and expert knowledge. Our goal is to define the functional significance and host-cell regulation of these important PTM pathways during infection, thereby revealing fundamental insight into the biochemical mechanisms that influence the outcome of viral infection and pathogenesis</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1734000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Pirbright Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Defining the role of SUMOylation during arbovirus infection</gtr:description><gtr:id>A8364DB1-6C08-4ABF-9E2B-260DEB31285A</gtr:id><gtr:impact>Research ongoing. Student selected for national presentation (microbiology society)</gtr:impact><gtr:outcomeId>56def9391967e0.45912159-1</gtr:outcomeId><gtr:partnerContribution>Cloning of cDNAs that express Aedes aegepti SUMOylation enzymes</gtr:partnerContribution><gtr:piContribution>Defining the biochemical activity of host SUMOylation enzymes expressed in Aedes aegepti.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute of Immunobiology and Epigenetics</gtr:department><gtr:description>Defining the role of the SUMO ligase ZNF451 in the regulation of PML NBs and intrinsic antiviral immunity</gtr:description><gtr:id>18DB694F-11DD-44BA-B3CB-E5582E800120</gtr:id><gtr:impact>none</gtr:impact><gtr:outcomeId>56def9efdcc138.11178970-1</gtr:outcomeId><gtr:partnerContribution>expression plasmids and polyclonal antibodies</gtr:partnerContribution><gtr:piContribution>Examining the role of ZNF451 during HSV-1 infection and host-cell intrinsic antiviral immunity</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>York University Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>X-ray crystallography studies of the purified ICP0 RING-finger domains from HSV-1 and VZV</gtr:description><gtr:id>45339B7F-0FAE-4A2F-BE8A-AFCFA38A29C9</gtr:id><gtr:impact>none</gtr:impact><gtr:outcomeId>56defaa3277c62.82893581-1</gtr:outcomeId><gtr:partnerContribution>Purification of recombinant proteins and X-ray crystallography trials</gtr:partnerContribution><gtr:piContribution>Provision of reagents for the purification of RING-domain containing viral E3 ubiquitin ligases expressed during HSV-1 and VZV infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Hospital of Philadelphia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Cellular and Molecular Therapeutics</gtr:department><gtr:description>Regulation of the DNA damage response during viral infection</gtr:description><gtr:id>BFB9BD0F-1B54-4BD4-BED9-B555602F21C0</gtr:id><gtr:impact>See assoc. publications list</gtr:impact><gtr:outcomeId>kmmWhDDHqLe-1</gtr:outcomeId><gtr:partnerContribution>Providing a detailed understanding of DNA repair mechanisms initiated in response to infection</gtr:partnerContribution><gtr:piContribution>Provision of biochemical expertise in the study of viral ubiquitin ligases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Center for Molecular Genetics (CGM)</gtr:department><gtr:description>SUMO modification and centromeres</gtr:description><gtr:id>3932C0E5-CA48-425E-8497-6081F48A9D3D</gtr:id><gtr:impact>Cell biology
Ubiquitin
SUMOylation
Biochemistry</gtr:impact><gtr:outcomeId>UJBSekcjUfe-1</gtr:outcomeId><gtr:partnerContribution>Cell biology analysis</gtr:partnerContribution><gtr:piContribution>biochemical analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cellular restriction of Influenza virus</gtr:description><gtr:id>052AB9EC-99FE-4BA3-A150-7B786E820537</gtr:id><gtr:impact>multi-disciplinary virology research</gtr:impact><gtr:outcomeId>C4ZgZdudnSQ-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents and expert knowledge within this area of research</gtr:partnerContribution><gtr:piContribution>Provision of reagents to study SUMOylation and ubiquitination during Influenza virus infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kansas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular Biosciences</gtr:department><gtr:description>The role of ICP0 in HSV-1 viral pathogenesis</gtr:description><gtr:id>FB798EF5-B5BF-48DF-A2B2-26BA2AA78A8B</gtr:id><gtr:impact>1. Boutell, C., R. Everett, J. Hilliard, P. Schaffer, A. Orr, and D. Davido. 2008. Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82:10647-56.
2. Smith, M. C., C. Boutell, and D. J. Davido. 2011. HSV-1 ICP0: paving the way for viral replication. Future Virol 6:421-429.</gtr:impact><gtr:outcomeId>eDRASVVn75A-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents and model system for viral pathogenesis</gtr:partnerContribution><gtr:piContribution>Provision of reagents, experimentation and publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beckman Researh Institute, City of Hope</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Reactivation of Latent HSV Requires a Specific Function encoded in RL2</gtr:description><gtr:id>E3392A02-A5A6-45EE-A02A-8CB1EE868B1F</gtr:id><gtr:impact>Ongoing research. No outputs recorded yet</gtr:impact><gtr:outcomeId>546239ce2ed747.69052354-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents</gtr:partnerContribution><gtr:piContribution>Provision of research reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Glasgow Virology Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87F04B8C-7B5A-4AA1-93B8-7EBE80B67B06</gtr:id><gtr:impact>This annual one day meeting aims to encourage interactions between virologists within Scotland and across the UK. It is usually very well attended (over 200 delegates last year), with groups from Glasgow, Edinburgh, St. Andrews, Dundee, Leeds, as well as other universities from around the UK. We attract a diverse audience, including local biotechnology companies, professional peers, undergraduates, and post-graduate students.</gtr:impact><gtr:outcomeId>56deff3cf127d0.18758421</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/researchinstitutes/iii/cvr/events/headline_430158_en.html</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kelvingrove Museum Science Weekend 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>82473BF2-4834-4090-BC65-8AF27EC00F4A</gtr:id><gtr:impact>We ran our 'Build a virus' and 'One Infection' activities - offering participants the opportunity to meet CVR scientists, learn about the structure of viruses and also key messages related to the transmission of viruses, and control measures including hygiene and vaccination.

Participants were asked to provide feedback on the activities to help us determine how to improve the activity in future. We have been asked to submit a proposal to run an activity during the Glasgow Science Festival in June 2015.</gtr:impact><gtr:outcomeId>5462aac4c83438.55629617</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PCR workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7F71F17B-4035-4B4C-82E1-19D94843BC86</gtr:id><gtr:impact>Since 2006, this activity has been delivered to more than 700 Scottish high school students. The teaching resources developed have been adopted by Learning Teaching Scotland to teach higher biology. Workshop has been praised in an HMIE report. Evaluation student feedback is very positive each year.

Our PCR workshop run in partnership with Glasgow Science Centre is a flagship/exemplar activity in high-school education. The PCR workshop has been cited by HMiE as an example of excellence. School pupils from all over Scotland travel to Glasgow to participate.</gtr:impact><gtr:outcomeId>Aaf1PpqRpB5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific consultant for BBC</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7F902757-AF59-4BA0-8675-BF0932775236</gtr:id><gtr:impact>Scientific consultant for a BBC public engagement program explaining the cause of cold sores</gtr:impact><gtr:outcomeId>58c96666e090d8.59612615</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scout's Science Day - 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>828D195B-3D6E-4519-B234-4107FBB356E6</gtr:id><gtr:impact>200 local scouts and guides attended a day of science engagement at the University of Glasgow where they had the opportunity to take part in a range of activities. All attendees took part in our 'Build a Virus' activity and meet with CVR scientists. These interactions gave the attendees the opportunity to ask questions and also learn a little more about viruses, their structure, transmission and control through group discussion with individual researchers. The activity was supported by 8 CVR researchers, providing an excellent opportunity for individual public engagement training and development.

The local Scout and Guide leaders are keen to facilitate another event in 2015.</gtr:impact><gtr:outcomeId>5462abffe85f91.57334976</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC DTP PhD studentship</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>28C87BF7-FDCA-4DDA-A4F3-25B482F6FDF2</gtr:id><gtr:outcomeId>56defb8bb84c31.02540860</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ISSF Univeristy of Glasgow polyomics funding scheme</gtr:description><gtr:fundingOrg>University of Glasgow</gtr:fundingOrg><gtr:id>ADDDDD0C-32A1-4B65-9877-C27C2EBE7E86</gtr:id><gtr:outcomeId>58c9707dec2a96.54559067</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>ASM Conference on Viral Manipulation of Nuclear Processes</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>American Society for Microbiology (ASM)</gtr:fundingOrg><gtr:id>30B5EBC6-BD21-475E-8726-6A95732AFD97</gtr:id><gtr:outcomeId>54623ab719f440.97802083</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIH Chromatin Control of Viral Infection</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>471DA751-FC09-426C-BF8C-F10B367A4051</gtr:id><gtr:outcomeId>54634e1a124bd7.75313473</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>King Abdulaziz University Scholarship scheme</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>King Abdulaziz University</gtr:fundingOrg><gtr:id>24E20FF0-C90E-4A6F-A70E-4841E60973CE</gtr:id><gtr:outcomeId>54634d797aada2.85259503</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Primary cell lines that have been transduced with lentiviral vectors expressing short hairpin RNAs (shRNAs) to deplete components of the SUMO conjugation pathway.</gtr:description><gtr:id>BDCD32E8-8714-4741-BDB3-6F57BD7D3125</gtr:id><gtr:impact>none currently. Research ongoing.</gtr:impact><gtr:outcomeId>q31u1Vaq6K7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>shRNA lentiviral cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The cloning, expression, and purification of various proteins implicated in ubiquitin biochemistry.</gtr:description><gtr:id>6673E506-EE8B-41F6-85D9-6AD75E98FB5E</gtr:id><gtr:impact>1. Lilley, C. E., M. S. Chaurushiya, C. Boutell, S. Landry, J. Suh, S. Panier, R. D. Everett, G. S. Stewart, D. Durocher, and M. D. Weitzman. 2010. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. Embo J 29:943-55.
2. Morris, J. R., C. Boutell, M. Keppler, R. Densham, D. Weekes, A. Alamshah, L. Butler, Y. Galanty, L. Pangon, T. Kiuchi, T. Ng, and E. Solomon. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462:886-90.
3. Morris, J. R., L. Pangon, C. Boutell, T. Katagiri, N. H. Keep, and E. Solomon. 2006. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum Mol Genet 15:599-606.</gtr:impact><gtr:outcomeId>hYfpNSYCL9W</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in vitro ubiquitin biochemsitry</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The cloning, expression, and purification of various proteins implicated in the regulation of SUMOylation.</gtr:description><gtr:id>B03D60C2-DDC7-4E57-80BB-7D100B6E877E</gtr:id><gtr:impact>multiple ongoing collaborations</gtr:impact><gtr:outcomeId>EA7oqfEkg3J</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in vitro SUMO biochemistry</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>viral nucleic acid represents a major immune stimulus. However, visualization of viral nucleic acid upon entry to host cells in relation to cellular proteins which mediate immune signalling has been problematic. We have optimized an efficient methodology for labeling viral DNA that has enabled us to detect viral nucleic acid within cells 15 minutes post-infection. This technique will prove extremely valuable in the identification of cellular processes that directly contribute to regulation of host immunity to virus infection.</gtr:description><gtr:id>FAAEF2E8-B2C2-40BC-82BD-87366F7B1FF8</gtr:id><gtr:impact>We are currently writing two manuscripts which describe the use of this technique</gtr:impact><gtr:outcomeId>58c96876d72315.99812853</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>single genome labelling technologies to study virus host-cell interactions</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>151EF511-0FA7-41C1-BD6A-66B889E484A1</gtr:id><gtr:title>Regulation of alphaherpesvirus infections by the ICP0 family of proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>doi_15232_0_048900_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE30C327-2BAC-485F-BA91-5322770E601C</gtr:id><gtr:title>Interplay between viruses and host sumoylation pathways.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>doi_15232_rmicro3015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5771FA40-3EC6-494B-8901-5AB25EEA6883</gtr:id><gtr:title>Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94637bff243aa9846abef2209ac3fbd0"><gtr:id>94637bff243aa9846abef2209ac3fbd0</gtr:id><gtr:otherNames>Domingues P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56def40d243e78.24843503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C0BE321-EFF4-4F93-AE83-48EB9F3C7233</gtr:id><gtr:title>A systematic analysis of host factors reveals a Med23-interferon-? regulatory axis against herpes simplex virus type 1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>doi_15232_at_1003514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A38F8836-1DCD-4022-B0FC-FB5E195C7210</gtr:id><gtr:title>Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>546237be83d588.24003051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAE332E-818B-4276-8DE2-CA7669174638</gtr:id><gtr:title>Host and viral determinants of Mx2 antiretroviral activity.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee8269c5d5f96af2db3dcc53cf06ab21"><gtr:id>ee8269c5d5f96af2db3dcc53cf06ab21</gtr:id><gtr:otherNames>Busnadiego I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>546237bea85d59.09800284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC650DA-C8E1-42A9-BC65-5140ADB41D18</gtr:id><gtr:title>Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5eb3dfb26a6148386a8eaf65bfc338"><gtr:id>8b5eb3dfb26a6148386a8eaf65bfc338</gtr:id><gtr:otherNames>Conn KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56def40cf0cab5.31518211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95A9FE1B-C218-454D-81AD-444B5BB94860</gtr:id><gtr:title>Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73dfc8e0ce67271a53b98f8bb5bb3137"><gtr:id>73dfc8e0ce67271a53b98f8bb5bb3137</gtr:id><gtr:otherNames>Alandijany T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a6619387ab765.80942727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89133DA8-242A-44C3-85C2-5234C4120B77</gtr:id><gtr:title>A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>5675e23249b5e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4518E79B-E93D-42BC-AE8C-505D4D41D278</gtr:id><gtr:title>SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75a267ef65956748d1b5fdaaa9a2c67"><gtr:id>a75a267ef65956748d1b5fdaaa9a2c67</gtr:id><gtr:otherNames>Brown JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>585d3a83e622f7.93286804</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12014/5</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>